Keyphrases
Corneal Fibrosis
100%
Corneal Wound Healing
100%
Sphingolipids
100%
Sphingosine-1-phosphate
85%
Fibrosis
57%
Sphingosine-1-phosphate Receptor (S1PR)
57%
Corneal Stromal Cells
42%
Myofibroblast
28%
Sphingosine Kinase 1 (SphK1)
28%
Corneal Scar
14%
Healing
14%
New Treatment Options
14%
Corneal Fibroblasts
14%
Recent Advances
14%
Complex Pathways
14%
Pathological Outcomes
14%
Cardiac Fibrosis
14%
In Vivo Model
14%
Knock-in Mouse Model
14%
Therapeutic Potential
14%
Extracellular Matrix
14%
Chemokines
14%
Scar
14%
Selective Inhibitor
14%
Sphingolipid Signaling
14%
Corneal Opacity
14%
Lung Fibrosis
14%
Corneal Transplantation
14%
Bioactive Sphingolipids
14%
Sphingolipid Metabolism
14%
Liver Fibrosis
14%
Sphingosine-1-phosphate Receptor 3
14%
Clinical Management
14%
Overaccumulation
14%
Economic Burden
14%
Positive Feedback Loop
14%
Blindness
14%
Treatment Options
14%
Societal Burden
14%
Corneal Transparency
14%
Keratocytes
14%
Effective Therapy
14%
Postsurgical
14%
Fibroblasts
14%
Growth Factors
14%
Medicine and Dentistry
Corneal Wound Healing
100%
Fibrosis
100%
Sphingolipid
100%
Sphingosine 1 Phosphate
63%
Receptor
27%
Stromal Cell
27%
Fibroblast
18%
Myofibroblast
18%
Cardiac Fibrosis
9%
Corneal Keratocyte
9%
In Vitro
9%
Infection
9%
Scar Formation
9%
Chemokine
9%
Fibrinogen
9%
Positive Feedback
9%
Sphingosine Kinase 1
9%
Pulmonary Fibrosis
9%
Sphingolipid Metabolism
9%
Clinical Management
9%
Sphingolipid Signaling
9%
Extracellular Matrix
9%
Cornea Opacity
9%
Growth Factor
9%
Liver Fibrosis
9%
Sphingosine 1 Phosphate Receptor
9%
Corneal Transplantation
9%
Diseases
9%
Pharmacology, Toxicology and Pharmaceutical Science
Fibrosis
100%
Sphingolipid
100%
Wound Healing
100%
Cornea Injury
100%
Sphingosine 1 Phosphate
63%
Receptor
27%
Growth Factor
9%
Knockout Mouse
9%
Liver Fibrosis
9%
Infection
9%
Chemokine
9%
Lung Fibrosis
9%
Fibrinogen
9%
Sphingosine Kinase 1
9%
Sphingosine 1 Phosphate Receptor
9%
Scar Formation
9%
Cornea Opacity
9%
Heart Muscle Fibrosis
9%
Diseases
9%